Skip to content

MIO / TeleRPM HH-XIII-T

by Mio Labs Inc.

MIO / TeleRPM HH-XIII-T (TeleBGM Lancing Device) is a glucose analyser IVD (FDA Class II; FDA product code NBW, System, Test, Blood Glucose, Over The Counter) made by Mio Labs Inc., listed in FDA GUDID since 20 Sep 2022 (UDI-DI 00850042929049), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00850042929049 UDI-DI Date20 Sep 2022ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Mio Lancing Device
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
MIO / TeleRPM
Generic name
Glucose analyser IVD, home-use
Model / Ref / Catalog
HH-XIII-T, TeleBGM Lancing Device
Primary DI / UDI-DI
00850042929049
FDA product code
NBW
GMDN term
Glucose analyser IVD, home-use
Device class
Class II
Regulation number
862.1345
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code NBW (System, Test, Blood Glucose, Over The Counter).

Other devices from Mio Labs Inc.

See all devices from Mio Labs Inc. →

Properties

  • Over-the-counter
Other properties (14, all answered No)